CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,920,727 | +154.9% | 76,021 | +53.6% | 1.34% | +43.2% |
| Q1 2023 | $1,145,809 | -11.6% | 49,495 | 0.0% | 0.93% | +21.2% |
| Q4 2022 | $1,296,769 | -21.1% | 49,495 | -40.8% | 0.77% | -17.9% |
| Q3 2022 | $1,643,000 | +84.8% | 83,551 | +64.4% | 0.94% | +74.7% |
| Q2 2022 | $889,000 | -19.8% | 50,834 | -25.0% | 0.54% | -23.8% |
| Q1 2022 | $1,109,000 | – | 67,777 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |